We observed that IGF2BP2 and IGF2BP3 expression was markedly upregulated in the central nervous system (CNS), lung, gastric tract, head, neck, pancreas, and lymphatic system cancers (Figure S1A). The gene discussed is IGF2BP2; the disease is lymphatic system cancer.